Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report

We report here a 66-year-old woman diagnosed with bronchioloalveolar carcinoma of the right lung cT4N2M0. The patient was from the Philippines, had never smoked, and tested positive for an EGFR mutation. She received gefitinib as neoadjuvant therapy for two months and displayed a partial response. T...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: López-González, A., Almagro, E., Salas, C., Varela, A., Provencio, M.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2013
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3949555/
https://ncbi.nlm.nih.gov/pubmed/26029620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2013.02.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires